Tattoos and Risk of Hematologic Cancer: A Population‐Based Case–Control Study in Utah
Cancer Medicine · 2024-10 · 13 (20)
DOI: 10.1002/cam4.70260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 23.10.2024. Verfasst von Rachel D McCarty und 15 weiteren Autor:innen. Beteiligte Einrichtung: Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Tattooing, Hematologic Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Background
Approximately one‐third of US adults have a tattoo, and the prevalence is increasing. Tattooing can result in long‐term exposure to carcinogens and inflammatory and immune responses.
Methods
We examined tattooing and risk of hematologic cancers in a population‐based case–control study with 820 cases diagnosed 2019–2021 and 8200 frequency‐matched controls, ages 18–79 years. We calculated odds ratios (OR) and 95% confidence intervals (CI) using multivariable‐adjusted logistic regression models.
Results
The prevalence of tattooing was 22% among Hodgkin lymphoma (HL) cases, 11% among non‐Hodgkin lymphoma (NHL) cases, 16% among myeloid neoplasm cases, and 15% among controls. Though there were no clear patterns of associations between ever receiving a tattoo and risk of HL, NHL, or myeloid neoplasms overall, in analyses restricted to ages 20–60 years, ever receiving a tattoo (OR 2.06 [95% CI 1.01, 4.20]) and receiving a tattoo 10+ years prior (OR 2.64 [95% CI 1.23, 5.68]) were associated with an aggregated group of rarer mature B‐cell NHLs. We also observed elevated risks for a 10+ year latency for myelodysplastic syndromes and chronic myeloid leukemia (OR 1.48 [95% CI 0.40, 5.41], and OR 1.24 [95% CI 0.45, 3.43], respectively).
Conclusions
Though estimates were imprecise, we found some suggestive evidence that tattooing may be associated with an increased risk of certain hematologic cancer subtypes. With an estimated 46% prevalence of tattooing in US individuals ages 30–49, additional studies are needed to understand the degree to which these exposures may be associated with hematologic cancer risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
- Department of Population Health Sciences Spencer Fox Eccles School of Medicine, University of Utah Intermountain Healthcare, University of Utah, Salt Lake City, Utah, USA.
- Department of Obstetrics and Gynecology, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah, USA.
- Lowell Center for Sustainable Production, University of Massachusetts Lowell, Lowell, Massachusetts, USA.
- Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
- Utah Cancer Registry, University of Utah, Salt Lake City, Utah, USA.
ORCID-Profile: Rachel D McCarty, Morgan M Millar, Lindsay J Collin, Katherine A Lawson-Michod, Jennifer A Doherty
Förderung
- NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
- Huntsman Cancer Institute, University of Utah
- Huntsman Cancer Foundation
- CDC HHS
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
McCarty, R. D., Trabert, B., Kriebel, D., Millar, M. M., Birmann, B. M., Grieshober, L., Barnard, M. E., Collin, L. J., Lawson-Michod, K. A., Gibson, B., Sawatzki, J., Carter, M., Yoder, V., Gilreath, J. A., Shami, P. J., & Doherty, J. A. (2024). Tattoos and Risk of Hematologic Cancer: A Population‐Based Case–Control Study in Utah. Cancer Medicine, 13(20). https://doi.org/10.1002/cam4.70260
Vancouver
McCarty RD, Trabert B, Kriebel D, Millar MM, Birmann BM, Grieshober L, et al. Tattoos and Risk of Hematologic Cancer: A Population‐Based Case–Control Study in Utah. Cancer Medicine. 2024;13(20). doi:10.1002/cam4.70260
BibTeX
@article{McCarty2024,
author = {McCarty, Rachel D and Trabert, Britton and Kriebel, David and Millar, Morgan M and Birmann, Brenda M and Grieshober, Laurie and Barnard, Mollie E and Collin, Lindsay J and Lawson-Michod, Katherine A and Gibson, Brody and Sawatzki, Jenna and Carter, Marjorie and Yoder, Valerie and Gilreath, Jeffrey A and Shami, Paul J and Doherty, Jennifer A},
title = {Tattoos and Risk of Hematologic Cancer: A Population‐Based Case–Control Study in Utah},
journal = {Cancer Medicine},
year = {2024},
volume = {13},
number = {20},
doi = {10.1002/cam4.70260}
}
EUVIMED